Results 31 to 40 of about 2,013 (145)
Long-Term Successful Treatment of Indolent Systemic Mastocytosis With Omalizumab. [PDF]
Fed Pract, 2021 This case study suggests that omalizumab may help prevent anaphylaxis and reduce disease burden associated with systemic mastocytosis, but further studies and formal clinical trials are needed to confirm these findings.
Weiss SL, Hyman JB, Carlson GS, Coop CA.
europepmc +4 more sources
Systemic mastocytosis: Case report with literature review [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2012 Introduction. Mastocytosis is a clonal neoplastic disorder of the mast cells. The clinical signs and symptoms of mastocytosis are heterogeneous ranging from indolent disease with a longterm survival to a highly aggressive neoplasm with survival of ...
Mitrović Mirjana +4 more
doaj +1 more source
Zdorovʹe Rebenka, 2022 Background. Mastocytosis is a disease characterized by the presence of mast cells in various organs. The skin is affected most often. Almost every patient diagnosed with mastocytosis has skin lesions.
O.L. Statkevych, T.V. Sviatenko
doaj +1 more source
Biochemical markers predictive for bone marrow involvement in systemic mastocytosis
Haematologica, 2008 Systemic mastocytosis is characterized by bone marrow involvement, which requires a bone marrow biopsy for diagnostic work-up. We questioned whether bone marrow involvement could be predicted using biochemical markers.
Marjolein L. Donker +7 more
doaj +1 more source
Case-control cohort study of patients' perceptions of disability in mastocytosis. [PDF]
PLoS ONE, 2008 BackgroundIndolent forms of mastocytosis account for more than 90% of all cases, but the types and type and severity of symptoms and their impact on the quality of life have not been well studied.
Olivier Hermine +20 more
doaj +1 more source
Challenging diagnosis of indolent systemic mastocytosis isolated to the GI tract. [PDF]
BMJ Case Rep, 2021 Mastocytosis is a rare group of disorders that presents with heterogenous phenotypes depending on the organ system involved. In the absence of cutaneous involvement—mast cell aggregates that may present as papules, nodules or plaques—classically associated with indolent systemic mastocytosis (SM), the diagnosis of this rare condition is particularly ...
Horton L +3 more
europepmc +3 more sources
Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice
Haematologica, 2016 Systemic mastocytosis is a heterogeneous disease characterized by the accumulation of neoplastic mast cells in the bone marrow and other organ organs/tissues.
Celalettin Ustun +15 more
doaj +1 more source
Pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: A case report. [PDF]
Int J Surg Case Rep, 2020 Abstract Introduction Systemic mastocystosis, a disorder of clonal mast cell expansion presents with symptoms of flushing, pruritus, musculoskeletal pain, gastrointestinal cramping and vascular instability. Patients with neuroendocrine tumors may present with similar symptoms due to the release
Sacco K +4 more
europepmc +3 more sources
Indolent Systemic Mastocytosis – a Case Report [PDF]
Serbian Journal of Dermatology and Venereology, 2017 Abstract Indolent systemic mastocytosis is a benign form of systemic mastocytosis characterized by an abnormal proliferation of mast cells either in the bone marrow or in numerous tissues. Case Report: A 27-year-old female patient was admitted to our department due to urticaria which started a month ago. Before the skin changes appeared,
Ljuba Vujanović +5 more
openaire +1 more source
Systemic Mastocytosis: Predominantly Involving the Bone, A Case Report [PDF]
Journal of Clinical and Diagnostic Research, 2013 Systemic mastocytosis (SM) is a rare clonal disorder of mast cells that can range from chronic smouldering type to aggressive mast cell leukaemia. It presents with non–specific symptoms like urticaria pigmentosa, unexplained flushing, hypotension and ...
Ketan P Mallya +4 more
doaj +1 more source